Board Advisor @ General Data Collection Ltd. Care Medcal Data Services Ltd. (February 2017 - Present)
Managing Partner @ China First Private Equity Management Co. Ltd (July 2016 - Present)
Executive Director-Asia @ (July 1996 - December 2020)
Executive Director- Asia @ (August 1996 - July 2016)
Advisor and Business Development-Game Changer, Breakthrough Medical Healthcare Solutions provider @ Newport Brain Research Laboratory Inc. (May 2013 - December 2018)
Chief Strategy Officer @ Dex Medical Device Co., Ltd (January 2014 - July 2016)
Executive Director @ ASIAGLO Ventures International Limited (July 2013 - June 2016)
Representative in Asia @ Endogene Ltd (April 2013 - March 2015)
Founder-Chairman @ NAP Limited (December 1998 - September 2009)
President @ NAL Pharma (January 1999 - January 2009)
T. Wu Education
University of South Australia
DBA (International Management)
2002-2009
Taipei Municipal Jianguo High School
University of South Australia
T. Wu Skills
Biotechnology
Business Development
Business Planning
Business Strategy
Commercialization
Due Diligence
Emerging Markets
Entrepreneurship
Finance
Investment Properties
Investments
Management
Medical Devices
Mergers & Acquisitions
New Business Development
Portfolio Management
Private Equity
Product Development
Start-ups
Strategic Consulting
Strategic Planning
Strategy
Venture Capital
T. Wu Summary
T. Wu, based in United States, is currently a Chief Strategy Officer at Corporation Name:帝視寰宇醫材股份有限公司 English Name:Disposcope Medical Equipment Co.,Ltd.. T. Wu brings experience from previous roles at Microbase Technology Corp., General Data Collection Ltd. Care Medcal Data Services Ltd., China First Private Equity Management Co. Ltd and AGGICA ASSETS Mangement. T. Wu holds a 2002 - 2009 DBA in International Management @ University of South Australia. With a robust skill set that includes Biotechnology, Business Development, Business Planning, Business Strategy, Commercialization and more. T. Wu has 1 emails on RocketReach.
Looking for a different T. Wu?
Find contact details for 700 million professionals.